Section Arrow
SMTI.NASDAQ
- Sanara MedTech
Quotes are at least 15-min delayed:2026/05/19 15:40 EDT
Regular Hours
Last
 22.87
+0.98 (+4.48%)
Day High 
22.87 
Prev. Close
21.89 
1-M High
24.33 
Volume 
15.56K 
Bid
22.8
Ask
22.96
Day Low
21.67 
Open
21.67 
1-M Low
17.77 
Market Cap 
200.60M 
Currency 美元 
P/E 379.05 
%Yield -- 
10-SMA 20.04 
20-SMA 19.6 
50-SMA 18.88 
52-W High 35.95 
52-W Low 16.0465 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.90/0.16
Enterprise Value
248.44M
Balance Sheet
Book Value Per Share
0.77
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
103.12M
Operating Revenue Per Share
6.51
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
WRBYWarby Parker24.88-3.77-13.16%2,513.5PE
XRAYDENTSPLY SIRONA9.725-0.095-0.97%-- 
MDLNMedline Inc37.62+1.6+4.44%32.95PE
AVTRAvantor7.72+0.12+1.58%-- 
NVSTEnvista Holdings Corp22.92-0.23-0.99%55.88PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.